Impressions: 847
This week,
SpeakPharma interviews Eleanor Row, Executive Director of Commercial at Quotient Sciences, a global drug development accelerator with state-of-the-art development, manufacturing and clinical testing facilities in the US and UK. Over the l...
Impressions: 4185
This
week, SpeakPharma interviews Dr. Peter Scholes, Chief Scientific Officer, Quotient Sciences, who talks about orphan drugs and some of the challenges drug developers face while developing them. In particular, Dr. Scholes tells us how Quotient Sc...